LIS wont trade sub $1.
LIS is a one stop battery shop where as PPK needs to provide BNNT for various companies to try and develop products and applications for it. LIS uses BNNT and that has cracked open the battery market. That took years to reach this point. LIS has proven technology after a 13 year development stage that addresses a multitude of applications. Our timing could not have been better. Every main industry uses batteries and that ready made market is not mature enough for BNNT on its own yet. That will take time but its coming. That is the true long term value of PPK. Batteries are the hottest sector to be in at the moment. The raw material feeders like lithium are also hot performers. Govts and all industries need a new battery. Its an industrial and environmental imperative. LIS is bound to get a percentage of this market imo. If it ever became the chosen technology over the years ahead, then pack your bags for a long holiday.
Once LIS sends out battery samples, companies can go and simply run bench tests and retrofit it into their products for testing. That wont take long. The accreditation of the product is independently done and others will no doubt do their own. In other words, its largely poking its head out of the lab and ready for market outside the fact that the company will keep developing an even better battery to get the most out of the technology. LIS current technology is not a dead end on development.
If LIS completes NDA's within the next 6-12 months with large manufactures, then look out. It will drag ppk up and vice versa on its success.
How much of the current $20 has some or all of LIS built into the stock price? Will it go even harder on listing? They are both worth owning for the longer haul.
- Forums
- ASX - By Stock
- LIS
- IPO - Li-S Energy Limited - 30 August 2021 #
IPO - Li-S Energy Limited - 30 August 2021 #, page-334
-
-
- There are more pages in this discussion • 167 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LIS (ASX) to my watchlist
|
|||||
Last
13.0¢ |
Change
0.005(4.00%) |
Mkt cap ! $80.02M |
Open | High | Low | Value | Volume |
13.0¢ | 13.0¢ | 13.0¢ | $650 | 5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 36552 | 12.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.0¢ | 14999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 36552 | 0.125 |
11 | 197363 | 0.120 |
2 | 16194 | 0.115 |
2 | 50000 | 0.110 |
1 | 5000 | 0.105 |
Price($) | Vol. | No. |
---|---|---|
0.130 | 14999 | 1 |
0.135 | 172128 | 5 |
0.140 | 61136 | 5 |
0.145 | 43995 | 2 |
0.150 | 83063 | 3 |
Last trade - 10.04am 16/07/2024 (20 minute delay) ? |
Featured News
LIS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online